CrushSCI.com
99.4Average days
53Median days
7Fastest days
350Longest days
1362025 publications

Paper Review Records

All Paper Review Records

29 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

32 days

Centanafadine: First Approval

Authors
Connie KangShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
Source PDF DOI Publisher page
236 days

Corneal Nerve Injury and Regeneration: Mechanisms, Clinical Consequences, and Emerging Therapeutic Strategies

Authors
Athar Shadmani; Anat Galor; Houri Esmaeilkhanian; Maja KosticShow moreShow less
Affiliations
1. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, USA; 2. Surgical Services, Miami Veterans Affairs Medical Center, Miami, USA; 3. Byers Eye Institute, Stanford School of Medicine, Palo Alto, USA; 4. School of Medicine, Saint Louis University, Saint Louis, USAShow moreShow less
Source PDF DOI Publisher page
281 days

Infections and the Opioid Epidemic: Changing Epidemiology and Treatment Options

Authors
Laura C. Fanucchi; Ellen Eaton; Nicholas Van Sickels; Michelle R. LofwallShow moreShow less
Affiliations
1. Division of Infectious Diseases and Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, USA; 2. Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA; 3. Division of Infectious Diseases, University of Kentucky College of Medicine, Lexington, USA; 4. Department of Behavioral Science and Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, USAShow moreShow less
Source PDF DOI Publisher page
71 days

Management of Multiple Sclerosis: Incorporating Recent Advances in Pathophysiology and Diagnosis to Guide Treatment Strategies

Authors
Moein Amin; Kaitlyn N. Palmer; Amjad Samara; Jeffrey A. CohenShow moreShow less
Affiliations
1. Mellen Center, Neurologic Institute, Cleveland Clinic, Cleveland, USAShow moreShow less
Source PDF DOI Publisher page
100 days

Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation

Authors
Shrey Sindhwani; Miles Thomas; Kanika Gehlaut; Harveen Kaur; Waqas Haque; Aditya Juloori; Noura J. ChoudhuryShow moreShow less
Affiliations
1. Department of Medicine, University of Chicago, Chicago, USA; 2. Department of Radiation Oncology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, India; 3. Department of Radiation and Cellular Oncology, University of Chicago, Chicago, USAShow moreShow less
Source PDF DOI Publisher page
21 days

Acoziborole: First Approval

Authors
Aisling McGuiganShow moreShow less
Affiliations
1. Springer Nature, Auckland 0754, New ZealandShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.